Genetic engineering reverses antibiotic resistanceBMJ 1997; 315 doi: https://doi.org/10.1136/bmj.315.7105.383f (Published 16 August 1997) Cite this as: BMJ 1997;315:383
- Kamran Abbasi
Researchers have developed a genetic engineering technique that for the first time allows drug resistant bacteria to be rendered drug sensitive. This may prove to be a cheaper method of negating antibiotic resistance than the current approach of developing new drugs.
A team of biologists from Yale University in the United States, led by Nobel prize winner Professor Sidney Altman, has used plasmids that contain synthetic genes coding for small oligoribonucleotides, called external guide sequences (EGSs), to infiltrate drug resistant strains of Escherichia coli (Proceedings of the National …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial